Acne scars, particularly atrophic ones, present a persistent challenge in cosmetic medicine and surgery, requiring extended and multifaceted treatment approaches. Poly-(lactic acid) injectable fillers show promise in managing atrophic acne scars by stimulating collagen synthesis. However, the utilization of needle-free injectors for delivering poly-(lactic acid) into scars remains an area requiring further exploration. In this article, a summary of the latest advancements in needle-free jet injectors is provided, specifically highlighting the variations in jet-producing mechanisms. This summary emphasizes the differences in how these mechanisms operate, offering insights into the evolving technology behind needle-free injection systems. The literature review revealed documented cases focusing on treating atrophic acne scars using intralesional poly-(lactic acid) injections. The results of these clinical studies could be supported by separate in vitro and animal studies, elucidating the feasible pathways through which this treatment operates. However, there is limited information on the use of needle-free jet injectors for the intradermal delivery of poly-(lactic acid). Clinical cases of atrophic acne scar treatment are presented to explore this novel treatment concept, the needle-free delivery of poly-(lactic acid) using a jet pressure-based injector. The treatment demonstrated efficacy with minimal adverse effects, suggesting its potential for scar treatment. The clinical efficacy was supported by histological evidence obtained from cadaver skin, demonstrating an even distribution of injected particles in all layers of the dermis. In conclusion, we suggest that novel needle-free injectors offer advantages in precision and reduce patient discomfort, contributing to scar improvement and skin rejuvenation. Further comprehensive studies are warranted to substantiate these findings and ascertain the efficacy of this approach in scar treatment on a larger scale.
Background: Injectable Poly‐L‐lactic acid (PLLA) is effective in restoring mid‐face volume and is widely used treating the nasolabial fold (NLF). This study aimed to compare the safety and efficacy of a novel PDLLA based product (PDLLA + non‐cross‐linked HA; Poly‐D, L‐lactic acid + hyaluronic acid) with that of a commonly used PLLA for NLF correction. Methods: In this multi‐center, randomized, split‐face, evaluator‐blinded study, 33 subjects received injections of the PDLLA based product on one NLF and PLLA injection on the other (three injections total, administered at 4‐week intervals). Wrinkle severity was assessed using standardized photographs taken at baseline (week 0); before the second and third injections (weeks 4 and 8); 4 weeks after the third injection (week 12); and 3 months after the final injection (week 24) using the Wrinkle Severity Rating Scale (WSRS). Safety data were collected through subject interviews and case report forms. Results: Both the PDLLA based product and PLLA significantly improved NLF wrinkle severity at all time points compared to baseline ( p < 0.001). The degree of improvement was comparable between the two products throughout the observation period. Conclusion: The PDLLA based product demonstrated non‐inferiority to PLLA for NLF correction. Further studies are needed to assess long‐term safety.
Background: Radiofrequency (RF) treatment improves chronologically aged and photodamaged skin with rhytids. The patterns of RF‐induced thermal tissue reactions can vary depending on the tissue resistance and treatment settings. In this study, we aimed to histologically and thermometrically evaluate the patterns of 6.78‐MHz monopolar and 1‐MHz mono‐/bipolar RF‐induced thermal tissue reactions in animal skin in vivo and ex vivo. Methods: Various settings of 6.78‐MHz monopolar RF at two different pulse mode characteristics (types S and H) were applied in vivo to minipigs, whereas various settings of 6.78‐MHz monopolar RF or 1‐MHz monopolar or bipolar RF were applied in vivo to rats. Subsequently, samples of the treated tissues were evaluated histologically. Ex vivo, porcine skin samples were treated with 6.78‐MHz monopolar RF, and real‐time noncontact infrared thermometry was used to monitor their surface and deep temperatures. Results: In the in vivo porcine skin study, 6.78‐MHz monopolar RF treatments at both pulse characteristics generated similarly effective thermal tissue reactions in the entire dermis and the fibrous septa of subcutaneous fat. However, RF treatment at the type‐S setting delivered RF energy preferentially through the fibrous septa of subcutaneous fat into the muscular fibrous layers. Meanwhile, RF treatment at the type‐H setting induced volumetric thermal reactions in the mid‐ to deep dermis and the fibrous septa of the subcutaneous fat layer. Thirty days post‐treatment, qualitatively increased numbers of thickened and elongated elastic fibers were noted in the lower reticular dermis and the fibrous septa of the subcutaneous fat layer across all experimental settings. RF treatments with three or five stacked passes using two pulse types resulted in different thermometric reactions in the surface and subcutaneous fat areas of ex vivo porcine skin. Additionally, the in vivo rat skin study revealed histopathologic differences based on experimental settings using 1‐MHz RF. Conclusion: Our histologic and thermometric pilot experiments demonstrated various patterns of RF‐induced early and late thermal tissue reactions based on the treatment settings, including 6.78‐MHz monopolar, 1‐MHz monopolar, and 1‐MHz bipolar RF delivery.